(XMME) Xtrackers MSCI Emerging - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00BTJRMP35 • Global Emerging Markets Equity
XMME: Stocks, Bonds, Emerging Markets, Equities
The Xtrackers MSCI Emerging Markets UCITS ETF 1C (XETRA:XMME) offers investors a strategic way to gain exposure to emerging markets, which are pivotal for growth-oriented portfolios. This ETF is structured to provide diversification across a broad spectrum of emerging economies, making it a valuable component for those seeking to enhance their global investment mix.
Domiciled in Ireland, the ETF benefits from a well-regulated and stable financial environment. Irelands favorable regulatory framework and tax efficiency make it an attractive choice for fund managers and investors alike, ensuring compliance with European standards and investor protections.
The ETF tracks the Morningstar EM TME NR USD index, a reputable benchmark that encompasses a wide range of emerging market equities. This index offers diversification across various countries and sectors, providing a comprehensive representation of the emerging markets landscape.
With an impressive Assets Under Management (AUM) of 5417.41M EUR, this ETF demonstrates significant liquidity and an established track record. Such size often attracts institutional investors, contributing to market stability and investor confidence.
While traditional valuation metrics like P/E, P/B, and P/S are not directly applicable to the ETF itself, investors should focus on the underlying indexs metrics. These figures provide insights into the health and potential of the emerging markets the ETF tracks.
Investors considering this ETF should adopt a long-term perspective, recognizing the growth potential of emerging markets despite associated risks. Diversification is key, and this ETF serves as a robust tool for achieving that within a global portfolio.
Additional Sources for XMME ETF
XMME ETF Overview
Market Cap in USD | 5,874m |
Category | Global Emerging Markets Equity |
TER | 0.18% |
IPO / Inception | 2017-06-21 |
XMME ETF Ratings
Growth 5y | 43.5% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -12.3 |
Analysts | - |
Fair Price Momentum | 50.24 EUR |
Fair Price DCF | - |
XMME Dividends
No Dividends PaidXMME Growth Ratios
Growth Correlation 3m | 23.6% |
Growth Correlation 12m | 80.6% |
Growth Correlation 5y | 25.1% |
CAGR 5y | 9.08% |
CAGR/Max DD 5y | 0.34 |
Sharpe Ratio 12m | 0.53 |
Alpha | 2.76 |
Beta | 0.65 |
Volatility | 17.61% |
Current Volume | 58.1k |
Average Volume 20d | 60.3k |
As of March 14, 2025, the stock is trading at EUR 53.97 with a total of 58,140 shares traded.
Over the past week, the price has changed by -1.85%, over one month by -4.41%, over three months by -2.53% and over the past year by +9.48%.
Partly, yes. Based on ValueRay Analyses, Xtrackers MSCI Emerging (XETRA:XMME) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 43.49 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XMME as of March 2025 is 50.24. This means that XMME is currently overvalued and has a potential downside of -6.91%.
Xtrackers MSCI Emerging has no consensus analysts rating.
According to ValueRays Forecast Model, XMME Xtrackers MSCI Emerging will be worth about 55.7 in March 2026. The stock is currently trading at 53.97. This means that the stock has a potential upside of +3.22%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 55.7 | 3.2% |